A clinical study is investigating the effects of
increased dietary fibre on immune cell function and blood
sugar levels for people living with type-2 diabetes, with
the aim of offering insight into better ways of managing the
disease.
“We’re looking to identify possible links
between the clinical benefits of increased dietary fibre
intake to changes in immune cell activity and metabolism,”
says Malaghan Institute Senior Research Fellow Dr David
O’Sullivan, who is running the study with Dr Olivier
Gasser in collaboration with Professor Jeremy Krebs at the
Centre for Endocrine, Diabetes and Obesity Research in
Wellington. The study is funded by the High Value Nutrition
National Science Challenge, Ko Ngā Kai Whai
Painga.
“By increasing our understanding of how
specific immune cells respond to diet and how this impacts a
disease like diabetes, in the future we may be able to
tailor therapies to achieve better outcomes,” says Dr
O’Sullivan.
Around a quarter of a million Kiwis are
affected by diabetes, with type-2 diabetes the most common,
and rates for Māori and Pasifika people 2-3 times higher
than people of European ethnicity according to the Manatū
Hauora Ministry of Health. The disease is characterised by a
combination of impaired insulin secretion and insulin
insensitivity leading to an inability to properly regulate
blood glucose levels. Elevated glucose levels substantially
increases the risk of secondary diseases such as heart
attacks and stroke.
At the immune system level, people
living with type-2 diabetes typically display chronic
low-grade inflammation and an increased inflammatory
response, markers that are thought to contribute to the
progression of this disease.
Unlike type-1 diabetes,
environmental factors such as obesity, unhealthy diet and
inactivity can play a role in the development of type-2
diabetes, and contribute to the worsening of symptoms.
However, healthy dietary changes can both reduce the risk of
disease onset and help regulate blood glucose level
fluctuation to a safer range. Diets high in fibre are
thought to have a greater effect.
The study will
compare participants with type-2 diabetes while on their
regular diet over the course of 14 weeks, before and after
natural fibre supplementation, to explore how increased
fibre intake impacts their immune cells and gut microbiota.
The study will also assess blood glucose levels and whether
the increase in fibre consistently lowers these
levels.
“Dietary fibre has a multitude of effects
from improving gut health to supporting a beneficial
microbiome and influencing immune responses” say Dr
O’Sullivan.
Fibre is digested by the bacteria that
live in our gut into smaller components known as short-chain
fatty acids. These molecules then pass through the lining of
the gut to be taken up by waiting immune cells and used for
various functions – including
metabolism.
“Increased dietary fibre and the
subsequent production of short chain fatty acids by gut
microbiota are known to influence immune cell function and
metabolic activity,” says Dr O’Sullivan.
“High
fibre diets correlate with a decrease in inflammatory
markers. We’ve seen in preclinical models that dietary
fibre can modulate immune cell metabolism, leading to a
rebalancing away from pro-inflammatory responses, which we
hope translates to better outcomes for people with type-2
diabetes.”
If you are interested in taking part
in this clinical study, are diagnosed with type-2 diabetes
and live in the Wellington region, contact DiabetesResearch@ccdhb.org.nz
for more
information.
© Scoop Media



















Discussion about this post